• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用脂质纳米颗粒进行靶向小干扰RNA递送

Targeted siRNA Delivery Using Lipid Nanoparticles.

作者信息

Jorge Andreia, Pais Alberto, Vitorino Carla

机构信息

Department of Chemistry, Coimbra Chemistry Centre, University of Coimbra, Coimbra, Portugal.

Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.

出版信息

Methods Mol Biol. 2020;2059:259-283. doi: 10.1007/978-1-4939-9798-5_14.

DOI:10.1007/978-1-4939-9798-5_14
PMID:31435927
Abstract

Efficient intracellular delivery of small-interfering ribonucleic acid (siRNA) to the target organ or tissues in the body is assumed as the main hurdle for a widespread use of siRNAs in the clinics. Solid lipid-based nanoparticles (SLNs) and derivatives can potentially fit this purpose by enabling to overcome the extracellular and intracellular physiological barriers affecting the delivery. For that, rational formulations and rational process designs are needed. This chapter addresses a comprehensive description and critical appraisal of the main production methods of this particular type of lipid nanoparticles and the leading strategies to prompt a targeted delivery of siRNA.

摘要

小干扰核糖核酸(siRNA)在体内有效递送至靶器官或组织被认为是siRNA在临床上广泛应用的主要障碍。基于固体脂质的纳米颗粒(SLNs)及其衍生物有可能通过克服影响递送的细胞外和细胞内生理屏障来实现这一目的。为此,需要合理的配方和合理的工艺设计。本章全面描述并批判性评估了这类脂质纳米颗粒的主要生产方法以及促进siRNA靶向递送的主要策略。

相似文献

1
Targeted siRNA Delivery Using Lipid Nanoparticles.使用脂质纳米颗粒进行靶向小干扰RNA递送
Methods Mol Biol. 2020;2059:259-283. doi: 10.1007/978-1-4939-9798-5_14.
2
Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.采用乳液法合成用于递送小干扰RNA的PLGA-脂质杂化纳米颗粒 用于递送小干扰RNA的PLGA-聚乙二醇-脂质纳米颗粒
Methods Mol Biol. 2017;1632:231-240. doi: 10.1007/978-1-4939-7138-1_15.
3
Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.用于癌症治疗中 siRNA 递送的基于脂质的纳米颗粒:范例与挑战。
Acc Chem Res. 2012 Jul 17;45(7):1163-71. doi: 10.1021/ar300048p. Epub 2012 May 8.
4
Lipid nanoparticles for short interfering RNA delivery.用于短干扰RNA递送的脂质纳米颗粒。
Adv Genet. 2014;88:71-110. doi: 10.1016/B978-0-12-800148-6.00004-3.
5
Lipid-based nanoparticles in the systemic delivery of siRNA.用于siRNA全身递送的脂质基纳米颗粒。
Nanomedicine (Lond). 2014 Jan;9(1):105-20. doi: 10.2217/nnm.13.192.
6
Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.基于脂质和聚合物的纳米颗粒 siRNA 递药系统用于癌症治疗。
Molecules. 2020 Jun 10;25(11):2692. doi: 10.3390/molecules25112692.
7
Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery.多功能自组装阴离子肽-脂质纳米复合物用于靶向 siRNA 递送。
Biomaterials. 2014 Sep;35(29):8406-15. doi: 10.1016/j.biomaterials.2014.06.003. Epub 2014 Jun 28.
8
pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.载有 siRNA 的脂质纳米粒的 pH 敏感性聚乙二醇化可改善其在肝细胞中的主动靶向和基因沉默活性。
J Control Release. 2017 Sep 28;262:239-246. doi: 10.1016/j.jconrel.2017.07.046. Epub 2017 Aug 1.
9
Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.载胆固醇油酸酯的阳离子固体脂质纳米粒作为高效基因沉默治疗的载体。
Int J Nanomedicine. 2018 May 30;13:3223-3233. doi: 10.2147/IJN.S158884. eCollection 2018.
10
In vivo delivery of RNAi with lipid-based nanoparticles.利用脂质纳米颗粒体内递送 RNAi。
Annu Rev Biomed Eng. 2011 Aug 15;13:507-30. doi: 10.1146/annurev-bioeng-071910-124709.

引用本文的文献

1
Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers.基于脂质的纳米系统用于将小干扰RNA递送至乳腺癌的研究进展
Pharmaceuticals (Basel). 2023 Jul 6;16(7):970. doi: 10.3390/ph16070970.
2
Nanoparticle delivery of siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages.纳米颗粒递送的 siRNA 通过抑制 DCs 和巨噬细胞的激活和分化来抑制同种免疫反应。
Sci Adv. 2022 Dec 21;8(51):eabq3699. doi: 10.1126/sciadv.abq3699.
3
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias.
用于治疗血脂异常的反义寡核苷酸和小干扰RNA
J Clin Med. 2022 Jul 4;11(13):3884. doi: 10.3390/jcm11133884.
4
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.用于呼吸道 COVID-19 疾病的 RNAi 治疗的纳米颗粒递送平台。
Int J Mol Sci. 2022 Feb 22;23(5):2408. doi: 10.3390/ijms23052408.
5
Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay.琼脂糖凝胶阻滞法测定阳离子聚合物与小干扰 RNA 的最佳比例。
Methods Mol Biol. 2022;2434:117-128. doi: 10.1007/978-1-0716-2010-6_7.
6
Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung.肺部对非病毒纳米颗粒(NP)递送系统的不良免疫反应。
J Immunotoxicol. 2021 Dec;18(1):61-73. doi: 10.1080/1547691X.2021.1902432.